Daniel Seifu

696 total citations
32 papers, 363 citations indexed

About

Daniel Seifu is a scholar working on Endocrinology, Diabetes and Metabolism, Emergency Medicine and Plant Science. According to data from OpenAlex, Daniel Seifu has authored 32 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Emergency Medicine and 6 papers in Plant Science. Recurrent topics in Daniel Seifu's work include HIV-related health complications and treatments (6 papers), Natural Antidiabetic Agents Studies (5 papers) and Pregnancy and preeclampsia studies (3 papers). Daniel Seifu is often cited by papers focused on HIV-related health complications and treatments (6 papers), Natural Antidiabetic Agents Studies (5 papers) and Pregnancy and preeclampsia studies (3 papers). Daniel Seifu collaborates with scholars based in Ethiopia, Sweden and United States. Daniel Seifu's co-authors include Wondwossen Amogne, Rudolph L. Gleason, Eyasu Makonnen, Markos Abebe, Alexander W. Caulk, Workeabeba Abebe, Christina Karlsson, Beyene Petros, Abebe Bekele and M.K. Menon and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Daniel Seifu

31 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Seifu Ethiopia 13 72 59 58 52 49 32 363
Chu-Chung Chou Taiwan 8 16 0.2× 47 0.8× 113 1.9× 138 2.7× 32 0.7× 12 409
Moaz M. Choudhary United States 8 22 0.3× 154 2.6× 55 0.9× 128 2.5× 32 0.7× 15 736
Lucija Kuna Croatia 11 69 1.0× 30 0.5× 15 0.3× 141 2.7× 62 1.3× 24 619
Matthew Kutner United States 2 22 0.3× 69 1.2× 55 0.9× 92 1.8× 31 0.6× 3 539
Adrienne Smith United States 10 15 0.2× 37 0.6× 18 0.3× 99 1.9× 32 0.7× 22 530
Cyril Breuker France 10 82 1.1× 62 1.1× 9 0.2× 113 2.2× 12 0.2× 33 405
J.-M. Lessinger Germany 7 74 1.0× 31 0.5× 9 0.2× 126 2.4× 37 0.8× 8 588
Aida Ortega‐Alonso Spain 14 56 0.8× 113 1.9× 31 0.5× 147 2.8× 33 0.7× 27 781
Bongjin Lee South Korea 13 50 0.7× 38 0.6× 75 1.3× 127 2.4× 6 0.1× 61 525
Joaquim Rigau Spain 8 29 0.4× 97 1.6× 30 0.5× 68 1.3× 10 0.2× 10 580

Countries citing papers authored by Daniel Seifu

Since Specialization
Citations

This map shows the geographic impact of Daniel Seifu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Seifu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Seifu more than expected).

Fields of papers citing papers by Daniel Seifu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Seifu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Seifu. The network helps show where Daniel Seifu may publish in the future.

Co-authorship network of co-authors of Daniel Seifu

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Seifu. A scholar is included among the top collaborators of Daniel Seifu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Seifu. Daniel Seifu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cross, Michael, Aster Tsegaye, Daniel Seifu, et al.. (2023). Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings. Annals of Hematology. 102(7). 1723–1729. 1 indexed citations
2.
Seifu, Daniel, et al.. (2021). BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients. Recent Patents on Anti-Cancer Drug Discovery. 16(3). 445–455. 1 indexed citations
4.
Seifu, Daniel, et al.. (2020). Solvent fractions of selected Ethiopian medicinal plants used in traditional breast cancer treatment inhibit cancer stem cells in a breast cancer cell line. BMC Complementary Medicine and Therapies. 20(1). 366–366. 10 indexed citations
5.
Tolessa, Tesfaye, et al.. (2020). <p>Rewarding Effect of <em>Catha edulis</em> (Khat) and the Sex Differences to the Responses in Swiss Albino Mice</p>. Psychology Research and Behavior Management. Volume 13. 279–289.
6.
Challa, Feyissa, Zeleke Geto, Terefe Gelibo, et al.. (2020). Prevalence of Hyperhomocysteinaemia and Associated Factors among Ethiopian Adult Population in a 2015 National Survey. BioMed Research International. 2020(1). 9210261–9210261. 12 indexed citations
7.
Yansouni, Cédric P., Daniel Seifu, Michael Libman, et al.. (2020). A Feasible Laboratory-Strengthening Intervention Yielding a Sustainable Clinical Bacteriology Sector to Support Antimicrobial Stewardship in a Large Referral Hospital in Ethiopia. Frontiers in Public Health. 8. 258–258. 9 indexed citations
8.
Erlandsson, Lena, Daniel Seifu, Markos Abebe, et al.. (2020). Association of Maternal Regulatory Single Nucleotide Polymorphic CD99 Genotype with Preeclampsia in Pregnancies Carrying Male Fetuses in Ethiopian Women. International Journal of Molecular Sciences. 21(16). 5837–5837. 8 indexed citations
9.
Makonnen, Eyasu, Getnet Yimer, Daniel Seifu, et al.. (2019). CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in Pharmacology. 10. 481–481. 13 indexed citations
10.
Seifu, Daniel, et al.. (2018). Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Women s Health. 18(1). 40–40. 46 indexed citations
12.
Seifu, Daniel, et al.. (2017). Antidiabetic and gastric emptying inhibitory effect of herbal Melia azedarach leaf extract in rodent models of diabetes type 2 mellitus. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Seifu, Daniel, Lars E. Gustafsson, Rajinder Chawla, et al.. (2017). Antidiabetic and gastric emptying inhibitory effect of herbal <em>Melia azedarach</em> leaf extract in rodent models of diabetes type 2 mellitus. Journal of Experimental Pharmacology. Volume 9. 23–29. 20 indexed citations
14.
Gleason, Rudolph L., Alexander W. Caulk, Daniel Seifu, et al.. (2016). Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia. Journal of Biomechanics. 49(13). 2584–2592. 20 indexed citations
15.
Amogne, Wondwossen, et al.. (2016). Lipid Peroxidation and Altered Antioxidant Profiles with Pediatric HIV Infection and Antiretroviral Therapy in Addis Ababa, Ethiopia. Journal of Tropical Pediatrics. 63(3). 196–202. 11 indexed citations
17.
Menon, M.K., et al.. (2015). Anti-retroviral Treatment Related Haematological Disorders among HIV- Infected Children Attending HIV Clinic at Yekatit 12 Hospital, Addis Ababa, Ethiopia. Lund University Publications (Lund University). 4(2). 1–18. 5 indexed citations
18.
Gleason, Rudolph L., Alexander W. Caulk, Daniel Seifu, et al.. (2015). Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia. PLoS ONE. 10(4). e0117125–e0117125. 31 indexed citations
19.
Platt, Manu O., Denise Evans, Philip M. Keegan, et al.. (2015). Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography. Molecular Biotechnology. 58(1). 56–64. 4 indexed citations
20.
Seifu, Daniel, et al.. (2014). AMELIORATION OF STREPTOZOTOCIN-INDUCED HYPERGLYCEMIA AND DYSLIPIDEMIA THROUGH ALOE DEBRANA. International Journal of Pharmacy and Pharmaceutical Sciences. 7(2). 290–293. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026